What is the function of hepatobiliary contrast agents in MRI?

What is the function of hepatobiliary contrast agents in MRI?

• A. They remain strictly extracellular and do not enter hepatocytes.
• B. They enhance only vascular structures.
• C. They are taken up by hepatocytes and excreted into bile, aiding liver and bile duct evaluation.
• D. They primarily highlight bone marrow.

Answer: (C)

Hepatobiliary contrast agents in MRI are designed to be taken up by healthy liver cells (hepatocytes) and excreted into the bile, providing imaging information about both liver tissue and the biliary system. After injection, these agents partially distribute in the extracellular space, but a portion is actively transported into hepatocytes via specific transporters. From there, they are excreted into bile, so during the hepatobiliary phase the liver parenchyma enhances and the bile ducts and gallbladder light up as well. This dual behavior lets you assess how well hepatocytes are functioning and visualize the biliary tree in one study. It also aids lesion characterization: lesions that don’t take up the agent stay relatively dark in the hepatobiliary phase, while those with functioning hepatocytes may take up and brighten, helping distinguish different liver pathologies. Additionally, you can evaluate biliary patency and leaks because bile ducts become bright due to the excreted contrast.

Hepatobiliary contrast agents in MRI are designed to be taken up by healthy liver cells (hepatocytes) and excreted into the bile, providing imaging information about both liver tissue and the biliary system. After injection, these agents partially distribute in the extracellular space, but a portion is actively transported into hepatocytes via specific transporters. From there, they are excreted into bile, so during the hepatobiliary phase the liver parenchyma enhances and the bile ducts and gallbladder light up as well. This dual behavior lets you assess how well hepatocytes are functioning and visualize the biliary tree in one study. It also aids lesion characterization: lesions that don’t take up the agent stay relatively dark in the hepatobiliary phase, while those with functioning hepatocytes may take up and brighten, helping distinguish different liver pathologies. Additionally, you can evaluate biliary patency and leaks because bile ducts become bright due to the excreted contrast.